摘要
肺囊性纤维化肺部疾病的特点是慢性、非解决先天免疫系统的激活和过度释放细胞因子及趋化因子如IL-8和免疫细胞,主要是中性粒细胞持续浸润,进入呼吸道。慢性感染和受损的免疫反应,最终导致肺损伤的特点是支气管扩张、肺气肿、肺纤维化。作为一个完整解释在肺纤维化疾病的夸张的炎症反应的知识的途径是缺乏的,了解这些途径可以揭示新的治疗目标,并引领新的治疗。因此,此处有一个强有力的理由鉴定在肺疾病的机制和途径下夸张的炎症反应。本文综述了炎症的肺囊性纤维化肺部疾病的发病机制中的作用,对异常信号参与趋化因子IL-8和肺囊性纤维化航空公司招募中性粒细胞过度表达的重点。研究结果表明,针对在免疫细胞信号传导通路(尤其是中性粒细胞)夸张的IL-8/IL-8受体(主要是CXCR2)可能代表了肺囊性纤维化肺部疾病的一种潜在的治疗策略。
关键词: 囊性纤维化,肺部炎症、CFTR,趋化因子信号,IL-8,CXCR2,NF-κB。
图形摘要
Current Drug Targets
Title:Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target
Volume: 17 Issue: 13
Author(s): Xiaoqing Guan, Yuning Hou, Fei Sun, Zhe Yang, Chunying Li
Affiliation:
关键词: 囊性纤维化,肺部炎症、CFTR,趋化因子信号,IL-8,CXCR2,NF-κB。
摘要: CF lung disease is characterized by a chronic and non-resolving activation of the innate immune system with excessive release of chemokines/cytokines including IL-8 and persistent infiltration of immune cells, mainly neutrophils, into the airways. Chronic infection and impaired immune response eventually lead to pulmonary damage characterized by bronchiectasis, emphysema, and lung fibrosis. As a complete knowledge of the pathways responsible for the exaggerated inflammatory response in CF lung disease is lacking, understanding these pathways could reveal new therapeutic targets, and lead to novel treatments. Therefore, there is a strong rationale for the identification of mechanisms and pathways underlying the exaggerated inflammatory response in CF lung disease. This article reviews the role of inflammation in the pathogenesis of CF lung disease, with a focus on the dysregulated signaling involved in the overexpression of chemokine IL-8 and excessive recruitment of neutrophils in CF airways. The findings suggest that targeting the exaggerated IL-8/IL-8 receptor (mainly CXCR2) signaling pathway in immune cells (especially neutrophils) may represent a potential therapeutic strategy for CF lung disease.
Export Options
About this article
Cite this article as:
Xiaoqing Guan, Yuning Hou, Fei Sun, Zhe Yang, Chunying Li , Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target, Current Drug Targets 2016; 17 (13) . https://dx.doi.org/10.2174/1389450117666151209120516
DOI https://dx.doi.org/10.2174/1389450117666151209120516 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomics Using Mammospheres as a Model System to Identify Proteins Deregulated in Breast Cancer Stem Cells
Current Molecular Medicine Chemoprevention of Lung Pathologies by Dietary n-3 Polyunsaturated Fatty Acids
Current Medicinal Chemistry Pharmacokinetic Study of Weekly (Days 1-5) Low-dose S-1 in Patients with Non-Small-Cell Lung Cancer
Reviews on Recent Clinical Trials Advances in Lipid-Based Subunit Vaccine Formulations
Current Immunology Reviews (Discontinued) Role of Physicochemical Properties of Chitin and Chitosan on their Functionality
Current Chemical Biology iRGD Co-Administration with Paclitaxel-Loaded PLGA Nanoparticles Enhance Targeting and Antitumor Effect in Colorectal Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Current Bioactive Compounds Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry The Role of Systemic Treatment and Radiotherapy in Malignant Mesothelioma
Current Respiratory Medicine Reviews Bioactive Albumin-Based Carriers for Tumour Chemotherapy
Current Cancer Drug Targets Editorial [Hot Topic: Prospective Clinical Role for Anticancer Garlic Organosulfur Compounds (Guest Editor: Hassan T. Hassan)]
Anti-Cancer Agents in Medicinal Chemistry NSCLC Structure-activity Relationship (SAR) Study of Diisothiocyanates for Antiproliferative Activity on A549 Human Non-small Cell Lung Carcinoma (NSCLC)
Letters in Organic Chemistry <i>In-silico</i> Studies and Wet-Lab Validation of Camptothecin Derivatives for Anti-Cancer Activity Against Liver (HepG2) and Lung (A549) Cancer Cell Lines
Current Topics in Medicinal Chemistry Seek and Destroy: The Use of Natural Compounds for Targeting the Molecular Roots of Cancer
Current Drug Targets From the Design to the Clinical Application of Thromboxane Modulators
Current Pharmaceutical Design The Impact of Molecularly Targeted Therapies Upon the Understanding of Leukemogenesis and the Role of Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia
Current Stem Cell Research & Therapy The Emerging Role of Vascular Endothelial Growth Factor (VEGF) in Vascular Homeostasis: Lessons from Recent Trials with Anti-VEGF Drugs
Current Vascular Pharmacology Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Current Medicinal Chemistry Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance
Current Cancer Drug Targets Integrated Analysis of mRNA-seq and miRNA-seq to Identify c-MYC, YAP1 and miR-3960 as Major Players in the Anticancer Effects of Caffeic Acid Phenethyl Ester in Human Small Cell Lung Cancer Cell Line
Current Gene Therapy